Immunity & Inflammation
The science behind our bodies' defense lines
New study reveals distinct triggers for gut and joint inflammation using germ-free mouse technology.
September 11, 2023
A fully automated machine learning algorithm predicts bone marrow inflammation in MRI scans
August 28, 2023
Inflammatory agent Interleukin-6 fires up complement system
August 24, 2023
New study challenges prevailing theory of liposomal accumulation and improves drug delivery to inflamed tissues
Study reveals that myeloid cells play a crucial role in the accumulation of liposomes in inflamed tissues
July 12, 2023
VIB researchers show how dendritic cells mature without causing an immune response
May 15, 2023
Too much salt can disrupt the energy metabolism in regulatory immune cells
February 7, 2023
Mutations in a key gene that was thought to be 'junk' DNA are linked to the risk of encephalitis after HSV-1 infection.
November 21, 2022
Training our immune system to recognize and attack tumors – immunotherapy – holds great promise for cancer therapy. New research by scientists from VIB, VUB, UGent, KU Leuven, and international partner Roche now shows why some patients don’t respond to immunotherapy. By clarifying the role of different cell types involved in the immune system’s response, this work by the team of Prof. Damya Laoui is an important step toward personalized treatment for cancer patients and is published in Cancer Research.
August 18, 2022